Price To Earnings Ratio 37.96 | Sector PE 70.55 |
PB Ratio 3.73 | Sector PB 8.91 |
EPS 47.42 | Dividend Yield 0.00 |
Today's Volume 399.935 K | 5 Day Avg. Volume 188.529 K |
PEG Ratio -1.06 | Market Cap. ₹ 29,200.00 Cr. |
Gland Pharma Limited is an India-primarily based totally general injectable-targeted company. The Company makes a speciality of complicated injectables and is engaged withinside the sterile injectables, oncology, and ophthalmology segments. The Company presents agreement development, very own development, file training and filing, era switch and production throughout a whole lot of transport systems. Its merchandise are to be had in liquid vials, lyophilized vials, pre-stuffed syringes, ampoules, bags, and drops. Its key molecules encompass Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, amongst others. Its healing merchandise classes encompass Anti Malarials, Anti-Infectives, Antineoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns, Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients. Its merchandise is offered throughout diverse countries, which encompass the United States, Europe, Canada, and others.